Trials / Sponsors / Genprex, Inc.
Genprex, Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients Small Cell Lung Cancer Extensive Stage | Phase 1 / Phase 2 | 2024-05-09 |
| Terminated | Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Canc Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2022-03-30 |
| Recruiting | Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osi Carcinoma, Non-Small Cell Lung | Phase 1 / Phase 2 | 2021-09-03 |
| Terminated | TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer Lung Cancer | Phase 1 / Phase 2 | 2014-02-01 |